AEON Biopharma, Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- AEON Biopharma, Inc. stock issued during period, value, new issues for the quarter ending 2026-06-30 was $887.00K, a 955.95% increase year-over-year.
- AEON Biopharma, Inc. stock issued during period, value, new issues for the quarter ending 2026-03-31 was $1.67M.
- AEON Biopharma, Inc. stock issued during period, value, new issues for the quarter ending 2025-12-31 was $67.00K, a 79.94% decline year-over-year.
- AEON Biopharma, Inc. stock issued during period, value, new issues for the quarter ending 2025-09-30 was $84.00K, a 68.00% increase year-over-year.
- AEON Biopharma, Inc. stock issued during period, value, new issues for fiscal 2025 was $235.00K, a 38.80% decline from fiscal 2024.
- AEON Biopharma, Inc. stock issued during period, value, new issues for fiscal 2024 was $384.00K.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-06-30 | $887.00K 10-Q · filed 2026-08-12 | $2.70M derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $1.67M 10-Q · filed 2026-05-14 | $1.90M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $67.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $235.00K 10-K · filed 2026-03-30 |
| 2025-09-30 | $84.00K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $84.00K 10-Q · filed 2026-08-12 | |
| 2024-12-31 | $334.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $384.00K 10-K · filed 2026-03-30 |
| 2024-09-30 | $50.00K 10-Q · filed 2025-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |